at Zacks.com (Wed, 8:21AM)
Kaufman Bros. is starting coverage on medical device firm Stryker (SYK) with a Buy and $57 PT, believing its strong cash flow will allow it to conduct acquisitions and buybacks. Kaufman is also positive on the growth outlook for both Stryker's orthopedic implant and surgical equipment businesses. Citi is concurrently upgrading Stryker to Buy.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Zacks.com (Jan 23, 2015)
at Zacks.com (Jan 15, 2015)
at Zacks.com (Jan 14, 2015)
at CNBC.com (Jan 14, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs